Abstract
EE511 Systematic Review of Cost Effectiveness Assessment Reports of Immune Checkpoint Inhibitors in Early and Advanced/Metastatic Stages of Cancer in France
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have